19 studies found for:    Open Studies | "Liver Cirrhosis, Biliary"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Liver Cirrhosis, Biliary"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Conditions: Liver Cirrhosis, Biliary;   Biliary Cirrhosis, Primary
Intervention:
2 Recruiting Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Other: conventional plus UC-MSC treatment;   Other: Conventional plus placebo treatment
3 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
4 Not yet recruiting Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: abatacept
5 Unknown  Family Studies in Primary Biliary Cirrhosis (PBC)
Condition: Biliary Cirrhosis, Primary
Intervention:
6 Recruiting Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Genetic: Genetic Analysis
7 Recruiting High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Dietary Supplement: High protein high fiber diet
8 Recruiting Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: NGM282;   Biological: Placebo
9 Recruiting Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   PBC
Interventions: Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic Acid
10 Recruiting Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: NGM282
11 Recruiting Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: budesonide;   Drug: budesonide placebo
12 Unknown  Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Conditions: Hepatitis C;   Hepatitis B;   Autoimmune Hepatitis;   Liver Cirrhosis, Biliary;   Cholangitis, Sclerosing
Intervention:
13 Not yet recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
14 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
15 Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
Condition: Cholestasis, Intrahepatic
Interventions: Drug: GSK2330672;   Drug: Placebo;   Drug: Ursodeoxycholic acid
16 Recruiting Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
Conditions: Cholestatic Liver Disorders;   Primary Sclerosing Cholangitis;   Primary Biliary Cirrhosis
Interventions: Drug: 11C-CSar;   Drug: ICG
17 Recruiting Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: PBC
Interventions: Drug: Bezafibrate;   Drug: placebo
18 Recruiting Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)
Condition: All Diagnosed Health Conditions
Intervention:
19 Unknown  Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases
Condition: Hepatobiliary Diseases
Intervention:

Indicates status has not been verified in more than two years